(Alliance News) - Indivior PLC on Wednesday said the primary and secondary endpoints were not met in a trial of AEF0117 in patients with cannabis use disorder. Read More
(Alliance News) - Stock prices in London opened lower on Thursday, with earnings from the UK and beyond largely falling short, after sentiment was already hurt by a tech sell-off in New York. Read More
(Alliance News) - London's FTSE 100 is called to open lower on Thursday, with a sell-off of US technology shares filtering through to trade in Europe and in Asia. Read More
(Alliance News) - Shares in Indivior PLC plunged on Tuesday after it flagged lower than expected sales of its opioid treatment, Sublocade, and said it expects to take a charge relating to schizophrenia drug, Perseris. Read More
(Alliance News) - Indivior PLC on Thursday confirmed that it has successfully transferred its primary listing to the Nasdaq Stock Market in the US. Read More
Indivior PLC - Chesterfield, Virginia-headquartered pharmaceutical maker - Reconfirms financial guidance for 2024 ahead of analyst 'teach-in' event in New York. Indivior also on Thursday is asking shareholders to approve moving its primary listing to New York from London. Read More
(Alliance News) - Indivior PLC on Thursday saw its shares fall despite reporting a quarterly uptick in profit, as it announced plans to switch its listing to New York. Read More
(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation. Read More
Indivior PLC - Chesterfield, Virginia-headquartered pharmaceutical maker - Chief Commercial Officer Richard Simkin sells 61,285 shares at GBP16.30 each, worth GBP998,946, in London on Thursday. Following this transaction, Simkin is now interested in 117,590 shares. Read More
Indivior PLC - Chesterfield, Virginia-headquartered pharmaceutical maker - Chief Commercial Officer Richard Simkin sells 30,000 shares on Wednesday at average GBP17.22 each, for a total of GBP516,600. Read More
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and Thursday and not separately reported by Alliance News: Read More
(Alliance News) - Indivior PLC on Thursday said it received final court approval for a settlement of a multi-district Suboxone litigation case. Read More